K
Kerala Institute of Medical Sciences (KIMS)
Multi-specialty tertiary care hospital
About Kerala Institute of Medical Sciences (KIMS)
Kerala Institute of Medical Sciences (KIMS) operates as a quaternary care hospital network with a significant presence across South India and the Middle East. The company was established as a public limited company in 1996 and commenced operations with its flagship hospital in Trivandrum in 2002. This facility was founded by Dr. M.I. Sahadulla, who serves as the Chairman and Managing director. Dr. Sahadulla, an internal medicine specialist, drew from his extensive 25-year experience in various roles, including physician and administrator at Saudi Aramco Hospitals, to establish a healthcare institution guided by American standards of quality and accreditation. His career also includes time with the National Health Services in the UK and Kerala's government medical colleges.
The business operates through a network of multi-specialty hospitals, providing a spectrum of services from primary to quaternary care. Its client base consists of patients in India and several GCC countries, including Oman, Bahrain, Saudi Arabia, Qatar, and the UAE. Revenue is generated by providing comprehensive healthcare services across more than 25 specialties, such as cardiac sciences, oncology, neurosciences, and organ transplantation. KIMS has demonstrated consistent growth through an affordable pricing model and strategic acquisitions, expanding from a single 250-bed facility to a network of over 2,000 beds. A significant milestone occurred in October 2023 when the US-based private equity firm Blackstone acquired a majority stake in KIMS Health as part of a larger deal to create one of India's largest hospital platforms, though Dr. Sahadulla continues to lead the company.
KIMS offers a broad range of medical services and is recognized for its advanced clinical capabilities and patient-centric approach. The flagship hospital in Trivandrum is a 650-bed quaternary care facility. The network has achieved numerous medical milestones, including performing Kerala's first liver and kidney transplant and pioneering complex surgeries in Tier 2 and Tier 3 cities. KIMS was the first hospital in India to receive both national (NABH) and international (Australian Council on Healthcare Standards International) accreditation in 2006. The institution also invests heavily in medical technology, such as the Tulsa-Pro system for non-invasive prostate treatment, the first of its kind in Southeast Asia. This commitment to quality and ethical practices is a core component of the company's operational philosophy.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Oct 2023 | $400M | $400M | CARE Hospitals Group | ↗ |
| GROWTH EQUITY VCOther financing | Mar 2017 | $200M | — | True North Managers · True North | — |
Growth signals
Latest recorded traffic for Kerala Institute of Medical Sciences (KIMS) is 120K monthly website visits, down 7.7% over the last three months. Kerala Institute of Medical Sciences (KIMS)'s team grew 71.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Kerala Institute of Medical Sciences (KIMS) in the Thiruvananthapuram ecosystem
The Kerala Institute of Medical Sciences (KIMS) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Ascent Capital (India)
Series B and later2 investors entered at this stage
True North Managers
True North
Other known investors1 additional known investor
CARE Hospitals Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kerala Institute of Medical Sciences (KIMS) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kerala Institute of Medical Sciences (KIMS)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









